NCT00004132
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +60 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,075 public trials
581 recruiting studies
Hemostatic Disorders trial results
NCT00005579
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
- Locations
-
- Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States
- Vermont Cancer Center Burlington, Vermont, United States
NCT00003007
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- William F. Bowld Hospital Memphis, Tennessee, United States
- Methodist Healthcare - Hospital of Memphis Memphis, Tennessee, United States
- Baptist Memorial Hospital Memphis, Tennessee, United States
- University of Tennessee, Memphis Memphis, Tennessee, United States
NCT00052416
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +26 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Fletcher Allen Health Care - University Health Center Campus Burlington, Vermont, United States
NCT00003395
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +70 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00003658
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00006019
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Bronchial Neoplasms, +54 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Completed
Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
NCT00052572
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
- Vermont Cancer Center at University of Vermont Burlington, Vermont, United States
NCT00022607
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- University of California Davis Cancer Center Sacramento, California, United States
- University of Chicago Cancer Research Center Chicago, Illinois, United States
NCT00090493
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States